Down-regulation of NAMPT expression by miR-182 is involved in Tat-induced HIV-1 long terminal repeat (LTR) transactivation

被引:42
作者
Chen, Xin-Yu [1 ]
Zhang, Hong-Sheng [1 ]
Wu, Tong-Chao [1 ]
Sang, Wei-Wei [1 ]
Ruan, Zheng [1 ]
机构
[1] Beijing Univ Technol, Coll Life Sci & Bioengn, Beijing 100124, Peoples R China
基金
北京市自然科学基金;
关键词
miR-182; SIRT1; NAMPT; Tat; HIV-1; OXIDATIVE STRESS; NAD BIOSYNTHESIS; METABOLISM; MICRORNAS; SIRT1; TRANSCRIPTION; SIRTUINS; PROTEIN; DEACETYLASE; PATHWAY;
D O I
10.1016/j.biocel.2012.11.002
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Tat's transactivating activity is controlled by sirtuin 1 (SIRT1) that connects HIV transcription with the metabolic state of the cell. Nicotinamide phosphoribosyltransferase (NAMPT) is a key enzyme in the salvaging pathway for the synthesis of nicotinamide adenine dinucleotide (NAD(+)) that is involved in energy metabolism. Host encoded microRNAs (miRNAs) may influence viral replication. In this study, our goal was aimed to investigate the regulation of miR-182 in TZM-bl cells and explore the mechanisms by which miR-182 influenced Tat-induced HIV-1 transactivation through targeting at down-regulation of NAMPT expression. We showed that miR-182 was up-regulated when Tat was expressed in T2M-bl cells. MiR-182 significantly inhibited NAMPT protein expression by acting on the 3'-UTR of the NAMPT mRNA. MiR-182 was involved in Tat-induced NAD(+) depletion, down-regulation of SIRT1 protein expression and activity, increased acetylation of p65. Forced expression of "miR-182 mimics" increased Tat-induced LTR transactivation. Our results uncover previously unknown links between Tat and a specific host cell miRNA that targets NAMPT. Our results suggest that strategies to augment NAMPT protein expression by down-regulation of miR-182 may have therapeutic benefits to prevent HIV-1 replication. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:292 / 298
页数:7
相关论文
共 48 条
  • [1] Preventing HIV-1 tat-induced neuronal apoptosis using antioxidant enzymes: Mechanistic and therapeutic implications
    Agrawal, Lokesh
    Louboutin, Jean-Pierre
    Strayer, David S.
    [J]. VIROLOGY, 2007, 363 (02) : 462 - 472
  • [2] NF-κB Activation, Dependent on Acetylation/Deacetylation, Contributes to HIF-1 Activity and Migration of Bone Metastatic Breast Carcinoma Cells
    Bendinelli, Paola
    Matteucci, Emanuela
    Maroni, Paola
    Desiderio, Maria Alfonsina
    [J]. MOLECULAR CANCER RESEARCH, 2009, 7 (08) : 1328 - 1341
  • [3] NAD+, Sirtuins, and Cardiovascular Disease
    Borradaile, Nica M.
    Pickering, J. Geoffrey
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2009, 15 (01) : 110 - 117
  • [4] Burgos ES, 2011, CURR MED CHEM, V18, P1947
  • [5] SIRT1 is a redox-sensitive deacetylase that is post-translationally modified by oxidants and carbonyl stress
    Caito, Samuel
    Rajendrasozhan, Saravanan
    Cook, Suzanne
    Chung, Sangwoon
    Yao, Hongwei
    Friedman, Alan E.
    Brookes, Paul S.
    Rahman, Irfan
    [J]. FASEB JOURNAL, 2010, 24 (09) : 3145 - 3159
  • [6] Targeting Sirtuin 1 to Improve Metabolism: All You Need Is NAD+?
    Canto, Carles
    Auwerx, Johan
    [J]. PHARMACOLOGICAL REVIEWS, 2012, 64 (01) : 166 - 187
  • [7] Chromatin dynamics associated with HIV-1 Tat-activated transcription
    Easley, Rebecca
    Van Duyne, Rachel
    Coley, Will
    Guendel, Irene
    Dadgar, Sherry
    Kehn-Hall, Kylene
    Kashanchi, Fatah
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS, 2010, 1799 (3-4): : 275 - 285
  • [8] Nampt: linking NAD biology, metabolism and cancer
    Garten, Antje
    Petzold, Stefanie
    Koerner, Antje
    Imai, Shin-ichiro
    Kiess, Wieland
    [J]. TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2009, 20 (03) : 130 - 138
  • [9] Gatignol A, 2007, ADV PHARMACOL, V55, P137, DOI 10.1016/S1054-3589(07)55004-0
  • [10] Tat is required for efficient HIV-1 reverse transcription
    Harrich, D
    Ulich, C
    GarciaMartinez, LF
    Gaynor, RB
    [J]. EMBO JOURNAL, 1997, 16 (06) : 1224 - 1235